SEC Filing Details
Document Details
Form
Filing Date
November 13, 2025
Document Date
November 12, 2025
Form Description
Amendment to a previously filed 8-K
Filing Group
Current Reports
Company
Enliven Therapeutics
Issuer
ENLIVEN THERAPEUTICS, INC.